TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases. La présente invention co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RAST, BRYSON, DELISLE, ROBERT KIRK, MARMSATER, FREDRIK, P, DAVIS, T. GREGG, TOPALOV, GEORGE T, JACKSON, LEILA, J, WRIGHT, A. DALE, CELESTE, LAURA L, LYSSIKATOS, JOSEPH, P, MUNSON, MARK, C, ZHAO, QIAN, KALLAN, NICHOLAS C, PHENEGER, JED, HICKEN, ERIK, JAMES, GROSS, STEFAN, D, ROBINSON, JOHN, E, GRESCHUK, JULIE MARIE, ALLEN, SHELLEY, SCHLACHTER, STEPHEN T
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases. La présente invention concerne les composés de formule (I), dans laquelle A, B, R1, R1a, R2, R3, R4, R5, R6, et R7 ont les significations données dans la spécification, qui sont des inhibiteurs de la tyrosine du récepteur utiles dans le traitement de maladies et troubles associés aux cellules immunitaires, tels que les maladies inflammatoires et auto-immunes.